Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
By David Douglas NEW YORK (Reuters Health) – Mammalian target of rapamycin (mTOR) inhibitor treatment has been linked with acute tubular necrosis (ATN) in four case reports from…
Brad Templeton, Board Member, Foresight Nanotech Institute, explains the next great medical revolution, the self-driving car. Car accidents are the 7th leading cause of death in the US,…
What is the bigger picture when it comes to the state of health in America? Are we living longer and healthier? What are the contributors, chronic disabilities and…
Salim Ismail, Founding Executive Director, Singularity University, gives you the top 5 medical breakthroughs by 2020 that will revolutionize medicine in the healthcare sector. Read more about Salim…
Atul Butte, MD, PhD, Chief, Division of Systems Medicine, Department of Pediatrics at Stanford University School of Medicine, discusses the intersection of biomedical research and computer technology. He…
West Nile virus remains an important public health concern since appearing in the United States back in 1999. Part of the challenge is dealing with the unpredictability of…
Jack Andraka, recipient of the 2012 Gordon E. Moore Award, explains the process of developing a cheap, fast, and 100% accurate diagnostic test for pancreatic cancer. Drawing from…
NEW YORK (Reuters Health) – A small study indicates that most patients with cutaneous B-cell lymphoma who respond well to rituximab relapse after about two years. On the…
NEW YORK (Reuters Health) – Contrary to a historically pessimistic outlook, high-risk prostate cancer can be controlled with moderate high-dose radiation treatment and prolonged androgen-deprivation therapy (ADT). That…
The Medicare program has different financial incentives. Under Medicare Fee-for-Service, patients are billed for each individual procedure they undergo. Under Medicare Advantage, patients have an annual fixed amount…
